Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bio-Path Holdings (BPTH)

Bio-Path Holdings (BPTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 34,260
  • Shares Outstanding, K 2,884
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,580 K
  • 60-Month Beta 3.28
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.74
  • Number of Estimates 1
  • High Estimate -0.74
  • Low Estimate -0.74
  • Prior Year -5.40
  • Growth Rate Est. (year over year) +86.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.80 +10.00%
on 09/05/19
13.41 -11.39%
on 08/16/19
-0.19 (-1.57%)
since 08/13/19
3-Month
10.80 +10.00%
on 09/05/19
17.53 -32.21%
on 07/16/19
-2.52 (-17.50%)
since 06/13/19
52-Week
1.61 +637.89%
on 01/22/19
73.52 -83.84%
on 03/07/19
-10.52 (-46.96%)
since 09/13/18

Most Recent Stories

More News
Bio-Path Holdings to Present at the H.C. Wainwright 21st Annual Global Investment Conference

Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs,...

BPTH : 11.88 (+5.04%)
Bio-Path Announces Patient Dosing in Amended Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs,...

BPTH : 11.88 (+5.04%)
Bio-Path: 2Q Earnings Snapshot

BELLAIRE, Texas (AP) _ Bio-Path Holdings Inc. (BPTH) on Thursday reported a loss of $2.5 million in its second quarter.

BPTH : 11.88 (+5.04%)
Bio-Path Holdings Reports Second Quarter 2019 Financial Results

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs,...

BPTH : 11.88 (+5.04%)
Bio-Path Holdings to Announce Second Quarter 2019 Financial Results on August 15, 2019

Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs,...

BPTH : 11.88 (+5.04%)
Bio-Path: 1Q Earnings Snapshot

BELLAIRE, Texas (AP) _ Bio-Path Holdings Inc. (BPTH) on Thursday reported a loss of $1.5 million in its first quarter.

BPTH : 11.88 (+5.04%)
Bio-Path Holdings Reports First Quarter 2019 Financial Results

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs,...

BPTH : 11.88 (+5.04%)
Bio-Path Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 16, 2019 / Bio-Path Holdings, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 16, 2019 at 8:30 AM Eastern...

BPTH : 11.88 (+5.04%)
Bio-Path Holdings to Announce First Quarter 2019 Financial Results on May 16, 2019

Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs,...

BPTH : 11.88 (+5.04%)
Biotech Brief: FDA Fast Tracking Innovative Breakthrough Therapies For Cancer Patients

A recent headline from a report released by Friends of Cancer Research, made the following eye-opening statement: "ONE OF THE BIGGEST TREATMENT BREAKTHROUGHS IN THE PAST FIVE YEARS WASN'T A DRUG, BUT A...

WVE : 23.94 (-0.66%)
ZSAN : 2.03 (+1.50%)
BPTH : 11.88 (+5.04%)
PFE : 36.91 (-0.99%)
MBRX : 1.22 (+3.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade BPTH with:

Business Summary

BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout...

See More

Key Turning Points

2nd Resistance Point 12.28
1st Resistance Point 12.08
Last Price 11.88
1st Support Level 11.54
2nd Support Level 11.20

See More

52-Week High 73.52
Fibonacci 61.8% 46.05
Fibonacci 50% 37.56
Fibonacci 38.2% 29.08
Last Price 11.88
52-Week Low 1.61

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar